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Abstract 
Background: The ChEMBL database is one of a number of public databases that contain bioactivity data on small 
molecule compounds curated from diverse sources. Incoming compounds are typically not standardised according 
to consistent rules. In order to maintain the quality of the final database and to easily compare and integrate data on 
the same compound from different sources it is necessary for the chemical structures in the database to be appropri-
ately standardised.
Results: A chemical curation pipeline has been developed using the open source toolkit RDKit. It comprises three 
components: a Checker to test the validity of chemical structures and flag any serious errors; a Standardizer which for-
mats compounds according to defined rules and conventions and a GetParent component that removes any salts and 
solvents from the compound to create its parent. This pipeline has been applied to the latest version of the ChEMBL 
database as well as uncurated datasets from other sources to test the robustness of the process and to identify com-
mon issues in database molecular structures.
Conclusion: All the components of the structure pipeline have been made freely available for other researchers 
to use and adapt for their own use. The code is available in a GitHub repository and it can also be accessed via the 
ChEMBL Beaker webservices. It has been used successfully to standardise the nearly 2 million compounds in the 
ChEMBL database and the compound validity checker has been used to identify compounds with the most serious 
issues so that they can be prioritised for manual curation.
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Introduction
The ChEMBL database is a freely available bioactiv-
ity database containing close to 2.5 million compound 
records on nearly 2 million unique chemical structures 
[1]. The compound structures and associated bioactiv-
ity data are extracted on a regular basis primarily from 
the medicinal chemistry literature. A growing number of 
researchers are also depositing experimental data directly 
in order to make these available in the public domain. 
Furthermore, ChEMBL contains a set of manually 
curated marketed drugs and clinical candidates as well as 
selected bioactivity data from other public databases such 
as BindingDB [2] and PubChem [3]. Bioactivity data on 
the same compound from all ChEMBL sources (scientific 
articles, deposited datasets and curated drug sources) are 
aggregated according to chemical structure. Compounds 
may be physically tested in bioassays as the so-called 
parent molecule or as one of a number of different salt 
forms. Scientists commonly wish to aggregate the data on 
these different forms on the basis of the common under-
lying parent structure, and so it is necessary to link these 
various forms of the “same” underlying parent molecule.
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In order to facilitate the use of the database, a key 
objective of the ChEMBL compound curation process 
is to standardise the chemical structures stored in the 
database and to assign a unique identifier to each distinct 
chemical structure regardless of the source. It is worth 
noting that there are over 5000 unique compounds in 
the ChEMBL database with data from ten or more dif-
ferent sources, and four compounds (doxorubicin, cipro-
floxacin, chloroquine and paclitaxel) each with data from 
over 1000 sources. For each ChEMBL release, more than 
50,000 new structures are added to the database, which 
makes manual curation and standardisation of the chem-
ical structures impracticable. Hence an automated proce-
dure is required.
The chemical structures submitted to the ChEMBL 
database are generally received as molfiles [4] but can also 
be in SMILES format [5]. There is no universal standard 
for these formats and the challenges of converting between 
chemical structure formats is well documented [6]. Even 
the simple process of loading molecules into and out of 
different cheminformatics packages can subtly change 
the structure, particularly if it was not well drawn in the 
first place. Chemical structures from the primary scientific 
literature are mostly manually drawn from the structural 
information in the papers prior to loading into ChEMBL. 
These structures are often represented in the publication 
as Markush structures with different R-groups shown in 
SAR (structure–activity relationship) tables. Compounds 
may also be shown with charges on acidic or basic groups, 
to indicate the form in which they are likely to interact 
with amino acid residues in a binding pocket. In some 
articles the compounds synthesised and reported are iso-
topically labelled. The ChEMBL compound curation pro-
cedure therefore needs to process molecules represented 
in all these ways (and more) to determine which com-
pounds are the same. Examples of these situations can be 
found in recent articles where data was extracted for the 
ChEMBL database [7–9].
A standardised V2000 molfile was chosen as the primary 
chemical structure representation in the database. The 
Standard InChI and the corresponding hashed InChIKey 
[10, 11] are used in ChEMBL as the measure of unique-
ness for a chemical structure and are calculated from the 
molfile using software provided by the InChI Trust, cur-
rently version 1.05 [12]. Thus, when compounds from 
different scientific articles have the same Standard InChI 
and InChIKey they are considered to be the same com-
pound and are assigned the same ChEMBL identifier 
(CHEMBL_ID). The use of the Standard InChI has a num-
ber of advantages in the context of the ChEMBL database. 
It was developed as an IUPAC open standard to enable 
information exchange and interoperability between large 
databases. The simple format of Standard InChI is also 
used by many other database providers and hence it is 
an ideal choice for an open database such as ChEMBL. 
However, unlike molfiles and SMILES, it was designed 
as an identifier and not as a structure format suitable for 
cheminformatics applications. For example, the Standard 
InChI is independent of the tautomeric form of a com-
pound and hence different tautomers of a compound will 
have the same standard InChI. As a consequence, they are 
considered in ChEMBL as being the same compound and 
hence have the same ChEMBL_ID. It should however be 
remembered that there are a few disadvantages to using 
Standard InChI as an identifier, including: its inability to 
recognise some 1,5 keto-enol tautomers as being the same 
compound; its inability to recognise cis/trans isomerism in 
organometallic compounds (e.g. cisplatin and transplatin) 
and it does not support the use of relative stereochemistry, 
only absolute or no stereochemistry. Despite these limita-
tions, it is a good compromise for a structural identifier 
for a public database such as ChEMBL. To aid interoper-
ability, a canonical SMILES is also generated from each 
primary molfile, but this is considered to be a secondary 
structure.
The challenges of registering compounds in a database 
and determining chemical uniqueness are not specific 
to ChEMBL. PubChem, the open chemistry database of 
over 100 million compounds maintained by the National 
Institutes of Health (NIH) has developed an automated 
and publicly available standardisation process based on 
OpenEye toolkits [13]. They utilise an isomeric canoni-
cal SMILES to identify unique structures and show that 
their method generates more unique structures than when 
Standard InChI is used to determine uniqueness. They 
also generate a canonical tautomer for their compounds. 
The ChEMBL group decided against the use of a canonical 
tautomer, for a number of reasons. Firstly, it is anticipated 
that the authors of an article in the medicinal chemis-
try literature will have worked on their compound set for 
some considerable time, performed docking and molecu-
lar modelling studies and will be well placed to assign the 
most appropriate tautomeric form, for example based on 
specific interactions with the target protein. Secondly, it is 
possible for tautomers to interconvert under experimen-
tal conditions. Thirdly, changing the tautomeric form of 
a compound can alter its stereochemistry by removing, 
or introducing, a chiral centre from a molecule, requiring 
often difficult decisions to be made about how to “merge” 
compounds/data with different chirality or which stereo 
form to create. Thalidomide is a well-known example of 
the second phenomenon which interconverts between the 
therapeutic R-enantiomer and the teratogenic S-enanti-
omer via the enol tautomer [14].
The Royal Society of Chemistry (RSC) developed 
the Chemical Validation and Standardization Platform 
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(CVSP) [15] to support compound deposition into their 
ChemSpider chemical database [16] and as a contribu-
tion to the Innovative Medicines Initiative (IMI) funded 
OpenPHACTS project [17] which aimed to standardise 
chemical structures from multiple databases. The CVSP 
methodology uses sets of SMARTS-based rules that can 
be tailored by the user. The code is available on GitHub 
[18] but currently has no obvious documentation and the 
interface is no longer available [19] although it is still pos-
sible for depositors to ChemSpider to use the rules to vali-
date their structures.
The United States Environmental Protection Agency 
(EPA) also strive to have well curated structures in their 
DSSTox database [20]. They have described, in detail, 
the complexity of the task and have undertaken extensive 
curation of their chemical structures using a combination 
of manual and automated methods. Much of their focus 
has been on resolving the mismatches between names, 
identifiers and structures between their compound set and 
those in the US National Library of Medicine databases 
ChemID [21] and PubChem. Due to the inability of the 
V2000 molfiles to distinguish relative and absolute stereo-
chemistry they have chosen to use V3000 molfiles as their 
preferred structure format. They also use an InChIKey cal-
culated using the ChemAxon JChem toolkit to determine 
uniqueness, but this differs from the Standard InChIKey 
discussed above. SMILES are provided for users not want-
ing to use V3000 molfiles, but they make the point that this 
results in a less rich representation of the structures. Their 
methods are based on a combination of commercial tool-
kits and their own manual curation tool [22].
The Global Substance Registration System (GSRS), 
developed by the regulatory authorities in the USA and 
Europe, creates a Unique Ingredient Identifier (UNII) 
for components of medicinal products which includes 
small molecules but also more complex molecules such 
as proteins and polymers [23]. This is a particularly useful 
resource for identifying the structures of specific phar-
maceutically relevant compounds, but it is less useful for 
the bulk curation of the larger set of bioactive molecules 
in the ChEMBL database.
Many commercial software providers also provide tool-
kits for standardising compound structures. These are 
widely used by large pharmaceutical and agrochemical 
companies where the precise annotation of a chemical 
structure is crucial for intellectual property protection. 
Those produced by ChemAxon and 3DS are examples of 
these toolkits [24, 25].
The legacy pipeline for processing compound struc-
tures prior to deposition into ChEMBL was based on 
commercial software and had evolved over more than 
10  years. During this time, more and more incorrect, 
unusual, and exceptional situations were identified and 
integrated into the pipeline. Unfortunately, these refine-
ments were increasingly making the code difficult to 
maintain and modify. In reviewing options for a sustain-
able future solution that also removed the dependence 
on commercial software it became apparent that none of 
the existing toolkits fitted the ChEMBL group’s require-
ments. Therefore, the decision was made to build a cura-
tion pipeline around the widely used open-source RDKit 
toolkit and its implementation of the MolVS molecule 
validation and standardisation tool [26, 27]. The result-
ing pipeline is now available as an open-source solution, 
freely available for the wider scientific community [28]. 
As part of this project the current rules used for curating 
ChEMBL structures have also been revised and rewritten 
to make them more sustainable. The resulting processes 
are designed and developed to suit the specific situation 
of ChEMBL, but the code can also be used by others “as 
is” or can be modified to suit other requirements.
It is important to note that this curation pipeline is not 
intended as a replacement for a similarly named stand-
ardiser tool [29] which was previously developed by 
the ChEMBL group as a contribution to the IMI eTOX 
project [30] and was specifically designed to standard-
ise molecules in preparation for molecular modelling 
applications.
The newly developed curation pipeline will now be 
described in more detail.
Methods
Three new components have been developed using the 
RDKit toolkit. Two of these components (Standardizer 
and GetParent) have been rewritten and adapted from 
rules originally implemented using a commercial soft-
ware toolkit. In contrast, the Checker component was 
developed more recently in an attempt to identify prob-
lem structures before they were added to the ChEMBL 
database.
Hence the new ChEMBL curation pipeline comprises 
three processes:
1. Checker: identifies and validates structures and iden-
tifies problems before they are added to the database
2. Standardizer: processes (standardises) chemical 
structures according to a set of predefined rules
3. GetParent: generates parent structures based on a set 
of rules and defined lists of salts and solvents
Checker component
The Checker component validates structures prior to the 
compounds being loaded into ChEMBL. If an error or 
problem is detected in the structure a score is reported 
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for the molecule; the score increases with the severity 
of the perceived problem. In the majority of cases com-
pounds are loaded into the database even if a warning 
flag is identified. The scores are recorded but at this point 
errors are not corrected. Instead, they are prioritised and 
subjected to subsequent manual curation, as time and 
degree of seriousness permits. A summary of the struc-
ture checks performed, and the resultant penalty scores 
assigned are shown in Table 1.
It is an individual user’s choice what they decide to 
do with molecules that return specific penalty scores. 
For ChEMBL, a penalty score of 7 is considered to be a 
fatal error and the molfile is not loaded into the data-
base. Examples of illegal input are, for example, unknown 
elements in the molfile, or molfiles that cannot be read 
in RDKit due to the inability to process their aromatic 
bonds. Molecules with a penalty score of 6 are loaded into 
the ChEMBL database but without a molfile, as it is con-
sidered that these have a significant issue with the struc-
ture, and it is preferable to fix the problem than have a 
badly formed molecule in the database. Most of the issues 
that give rise to a penalty score of 6 are self-explanatory 
and are described in Table 1. If the penalty score is 5 or 
2 the molecule is loaded but the compounds are also pri-
oritised for manual curation. Again, many of the 5 and 2 
penalty scores are self-explanatory, but the stereo mis-
match errors perhaps need further explanation. These 
are reported when the number of stereocentres perceived 
by the following calculation methods differ:
• Mol: number of atoms where a wedged bond starts
• InChI: number of tetrahedral stereocentres
• RDKit: number of atomic stereocentres remaining 
after calling Chem.AssignStereochemistry()
Hence the “InChi_RDKit/Mol stereo mismatch” 
warning message indicates that the InChI and RDKit 
algorithms perceive the number of stereocentres to be 
the same but different from the molfile. “Mol/Inchi/
RDKit stereo mismatch” means that all three meth-
ods perceive different stereocentre counts. The major-
ity of these issues occur in complex molecules such as 
bridged bicyclic molecules that are badly drawn. As 
Standard InChI is derived from the molfile, the errors 
where the molfile and InChI differ in their stereocentre 
counts are given a higher penalty score [5] than when 
they are the same but different from the RDKit stereo 
count [2].
The InChI software may give a number of warnings. 
These are also reported by the ChEMBL Checker module. 
Some of these are considered important, but others such 
as “InChI: Omitted undefined stereo”, “InChI: Charges 
were rearranged”, “InChI: Ambiguous stereo”, “InChI: 
Proton(s) added/removed” and “InChI: Not chiral” are 
generated for large numbers of molecules. These either 
reflect the reorganisation of atoms in order to generate 
the InChI or are related to stereochemical ambiguity aris-
ing, for example, from the fact that the compound is a 
racemate; these are not considered issues for a database 
such as ChEMBL. Therefore, these are given a low pen-
alty score [2]. However, in other contexts they might be 
more relevant and so are reported in the Checker output.
Standardizer component
The standardisation rules implemented in the ChEMBL 
database are based largely on the FDA/IUPAC guide-
lines [31, 32]. Whilst the aim is to adhere to these rules 
as closely as possible, the practical reality is that submit-
ted compounds are sometimes drawn imperfectly or the 
structures are ambiguously defined in the original pub-
lication or by the depositor. An automated standard-
iser can only safely correct some of the potential issues 
and the standardisation rules, currently encoded in the 
Standardizer component, are outlined here.
For certain compound types, particularly organometal-
lic and those with a large number of boron atoms, a flag 
is set (exclude flag) and no attempt is made to standard-
ise them. This is largely due to the V2000 molfile format 
used by ChEMBL being unable to accurately represent 
coordination bonds. For this reason, although the bioac-
tivity data on these compounds is available in ChEMBL, 
the chemical structures are not curated nor provided in 
the release version of the database.
The first step in the standardisation process is therefore 
to exclude molecules if they contain more than 7 boron 
atoms or any of the following atoms: [Sc], [Ti], [V], [Cr], 
[Mn], [Fe], [Co], [Ni], [Cu], [Ga], [Y], [Zr], [Nb], [Mo], 
[Tc], [Ru], [Rh], [Pd], [Cd], [In], [Sn], [La], [Hf], [Ta], [W], 
[Re], [Os], [Ir], [Pt], [Au], [Hg], [Tl], [Pb], [Bi], [Po], [Ac], 
[Ce], [Pr], [Nd], [Pm], [Sm], [Eu], [Gd], [Tb], [Dy], [Ho], 
[Er], [Tm], [Yb], [Lu], [Th], [Pa], [U], [Np], [Pu], [Am], 
[Cm], [Bk], [Cf], [Es], [Fm], [Md], [No], [Lr], [Ge], [Sb].
The following standardisations are then made to the 
molecule (where they occur):
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1. Standardise unknown stereochemistry
Before
Standardisation
After 
Standardisation
a. Change “wiggly” bonds on sp3 
carbons denoting unknownstereo 
to show  no stereo
b. Set either or unknown cis/trans  
bonds to crossed bonds instead of
showing them as “wiggly” bonds
Table 1 Penalty scores and annotation that are output from the Checker module
7 is the most serious penalty score and 2 the least important
Penalty score Penalty explanation
7 Error-9986 (Cannot process aromatic bonds)
Illegal input
InChI: Unknown element(s)
6 All atoms have zero coordinates
InChI: Accepted unusual valence(s)
InChI: Empty structure
Molecule has 3D coordinates
Molecule has a radical that is not found in the known list
Molecule has six (or more) atoms with exactly the same coordinates
Number of atoms less than 1
Polymer information in mol file
V3000 mol file
5 InChI_RDKit/Mol stereo mismatch
Mol/Inchi/RDKit stereo mismatch
RDKit_Mol/InChI stereo mismatch
Molecule has a bond with an illegal stereo flag
Molecule has a bond with an illegal type
Molecule has a crossed bond in a ring
Molecule has two (or more) atoms with exactly the same coordinates
2 InChI_Mol/RDKit stereo mismatch
Molecule has a stereo bond in a ring
Molecule has an atom with multiple stereo bonds
Molecule has a stereo bond to a stereocenter
Molecule has the 3D flag set for a 2D conformer
Other InChI Warnings
2. Clear S Group data from the molfile
3. Generate a kekulé form of the structure
4. Remove explicit H atoms except:
a. Hs where an isotope of hydrogen has been spe-
cifically set
b. Hs that have a wedged or dashed bond to them
c. Hs bonded to atoms with tetrahedral stereo-
chemistry set (“Chiral Hs”). This is an example:
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d. Hs bonded to atoms in a non-default valence 
state that are not simply protonated. An example 
is phosphinic acid:
5. Normalise structure:
a. Fix hypervalent nitro groups
b. Convert covalently drawn alkaline metals con-
nected to O or N to ionic forms (e.g. NaO to 
Na+ O−)
c. Fix incorrect amide tautomers, e.g. N=COH to 
HNC(=O)
d. Standardise sulphoxides to charge-separated 
form
e. Standardise diazonium N to N+
f. Ensure quaternary N is charged
g. Ensure trivalent O is charged
h. Ensure trivalent S is charged
i. Ensure halogen not bonded to a neighbouring 
atom is charged
6. Ensure molecule is neutralised, if possible, by:
a. Adding or removing Hs
b. Moving Hs from one atom to another (including 
between components)
Note that if the Hs could be added to more than one 
atom an arbitrary choice is made but this is done canoni-
cally so the result will always be the same for a given 
molecule
7. Normalise (straighten) triple bonds and allenes
In the context of the ChEMBL database, it is the mol-
files standardised according to these rules that are stored 
in the database and which are in turn the structures made 
available to the database users.
GetParent component
Many compound registration systems, including the 
ChEMBL database, identify compounds that are related 
by virtue of being a salt form of a common parent struc-
ture. Therefore, as part of the ChEMBL compound cura-
tion pipeline, molecules are identified where the molfile 
contains more than one connected component as well as 
molecules containing atoms with specified isotopes.
The GetParent module is applied to just those com-
pounds that match one or both of these criteria. All 
information about isotopes is removed, as are solvents 
and salts present in the molfile which match any of the 
components in the defined salt and solvent lists. Hav-
ing removed all salts (e.g. Na+ that might be included 
to neutralise a carboxyl group), the resulting molecule 
is neutralised and a new molfile created as the “par-
ent” molecule. Compounds containing more than one 
component that are genuine mixtures (i.e., all of the 
components are absent from the salt and solvent lists) 
has, in the context of the ChEMBL database, its par-
ent registered as the identical mixture. For cases such 
as sodium chloride and sodium citrate, where both 
components are in the salt list, the GetParent mod-
ule does not remove any component and the parent 
remains the same as the salt. Here again, the parent 
is registered as the multicomponent mixture. Com-
pounds containing any of the excluded atoms described 
above have their isotopes and solvents removed and 
then parents created, so that bioactivity data can sub-
sequently be aggregated. For example, the antimony-
containing compound sodium stibogluconate has two 
versions in ChEMBL 26, both with bioactivity data: 
CHEMBL3754364 is a version with water of crystallisa-
tion and CHEMBL3764926 is a version without. These 
are annotated as related forms so that the bioactiv-
ity data can be seen aggregated in the database. Cya-
nocobalamin is a cobalt-containing compound which 
is recorded as a parent and three different isotopes in 
the database (CHEMBL2110563, CHEMBL2104118, 
CHEMBL2104381 and CHEMBL2096655). Again, 
the GetParent module enables their data aggrega-
tion. Organometallic compounds do not however have 
salts removed due to the complexity of how they are 
often represented in the deposited molfile. For exam-
ple, this is often achieved by drawing them as dis-
connected components as is the case for transplatin 
(CHEMBL1386) which was deposited into the database 
as N.N.[Cl−].[Cl−].[Pt+2]. Removal of the chloride 
and ammonia components would incorrectly result in a 
platinum ion as the parent.
The list of salts used in ChEMBL is based on the USAN 
Council’s list of pharmacological salts [33]. Additional 
entities have been added to this list where a significant 
number of examples have been present in ChEMBL data-
sets. The GetParent module will remove salts regardless 
of: (i) the charge status (e.g. acetic acid or acetate, Cl− 
or HCl); (ii) whether or not stereochemistry is depicted 
(e.g. tartaric acid); (iii) cis/trans isomers (e.g. maleic and 
fumaric acid). The salts and solvents files are available in 
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the GitHub repository [28]. Currently, these files con-
tain 162 salts and 9 solvents respectively. This list will be 
maintained and extended if additional salts and solvents 
are identified.
For the avoidance of any doubt, although parents, salts, 
solvents, isotopes and mixtures are all identified using 
the process just described, the bioactivity data recorded 
in ChEMBL is registered against the form it was meas-
ured on. The aggregation by parent structure is under-
taken to make it easier to identify all the data for salts and 
isotopes of a common parent. For example, paroxetine 
(CHEMBL490) has bioactivity data determined for the 
parent molecule, two salts, one salt/solvent mixture and 
two different isotopes as well as there being an additional 
salt registered as an FDA approved drug. Another exam-
ple is amphetamine (CHEMBL405), which has bioactiv-
ity data in ChEMBL for eight different salts in addition 
to the parent amphetamine and an additional two salts 
that are recorded in drug sources such as the FDA orange 
book [34]. The parent aggregation process makes this 
data easily identified and grouped. This is illustrated in 
Fig. 1 for these two compounds.
Availability of structure curation pipeline
The code for the pipeline has all been developed using 
the RDKit toolkit (version 2019.09.2.0). It is open source 
and publicly available in GitHub [28], currently as ver-
sion 1.0.0. A conda package is also available to facilitate 
installation [35]. The Standardizer, Checker and GetPar-
ent functions are also integrated in the ChEMBL Beaker 
webservices and can be used in this way  via the ‘check’, 
‘getParent’ and ‘standardize’ endpoints [36]. Any new fea-
tures developed by the ChEMBL group will be added to 
the repository and comments and suggestions from oth-
ers are welcomed.
Results and discussion
One of the objectives in developing the new curation 
pipeline was to improve the quality of the chemical struc-
tures in the ChEMBL database. As the rules implemented 
Parent Other Forms
Fig. 1 Examples of the multicomponent forms of paroxetine and amphetamine and how they have been aggregated by use of the GetParent 
component
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in the new Standardizer and GetParent modules were 
largely based on the original ChEMBL rules developed 
over the last 10  years it is difficult to unambiguously 
quantify this improvement. To provide a consistent 
starting point, therefore, the current 1.9 million com-
pounds in the latest release of ChEMBL (ChEMBL 26) 
have been completely re-standardised and the par-
ents regenerated for the whole database using the new 
pipeline.
Checker component
To investigate the utility of the Checker module three 
very different compound sets were used. These were: a 
set of compounds recently extracted (by manual drawing) 
from the medicinal chemistry literature by the ChEMBL 
data extractors; a set of compounds from SureChEMBL, 
the patent database where the chemical structures are 
obtained by entity recognition followed by name or image 
to structure conversion [37] and a randomly selected 
compound set from PubChem (SIDs) as initially submit-
ted by the depositors and prior to any compound stand-
ardisation. These three datasets are provided as structure 
data files (sd files) in the Supplementary Information S1, 
Table 2 Checker total number of  the  different penalty scores output from  subjecting the  ChEMBL Literature set, 
the SureChEMBL set and the PubChem Set to the Checker process
Note that the number of penalty scores output is not the same as the number of compounds as some compounds return multiple penalty scores
Penalty score Penalty explanation SureChEMBL ChEMBL Literature PubChem
7 Error-9986 (Cannot process aromatic bonds) 4 0 0
Illegal input 0 1 0
InChI: Unknown element(s) 3 0 1355
6 All atoms have zero coordinates 0 0 12
InChI: Accepted unusual valence(s) 73 1 2155
InChI: Empty structure 0 1 5824
Molecule has 3D coordinates 0 1 1024
Molecule has a radical that is not found in the known list 187 1 252
Molecule has six (or more) atoms with exactly the same coordinates 3 0 206
Number of atoms less than 1 0 1 5824
Polymer information in mol file 2 0 0
V3000 mol file 594 0 0
5 InChI_RDKit/Mol stereo mismatch 588 152 339
Mol/Inchi/RDKit stereo mismatch 0 0 28
RDKit_Mol/InChI stereo mismatch 23 22 1479
Molecule has a bond with an illegal stereo flag 1054 0 0
Molecule has a bond with an illegal type 6 0 0
Molecule has a crossed bond in a ring 34 36 134
Molecule has two (or more) atoms with exactly the same coordinates 4 5 2367
2 InChI_Mol/RDKit stereo mismatch 0 55 307
Molecule has a stereo bond in a ring 2359 5763 7061
Molecule has an atom with multiple stereo bonds 1493 52 3660
Molecule has a stereo bond to a stereocenter 331 27 983
Molecule has the 3D flag set for a 2D conformer 0 0 5
Other InChI Warnings 20188 34052 170678
No errors 15015 111137 177815
Table 3 Percentages of  the  compounds in  each 
of the SureChEMBL, ChEMBL and PubChem sets returning 
each value as their maximum penalty score
The highest (most serious) resulting score is the one recorded for each 
compound
Penalty score SureChEMBL ChEMBL 
Literature
PubChem
7 0.01 0.00 0.45
6 1.62 0.00 3.14
5 2.72 0.15 1.00
2 (non InChI) 6.92 3.90 3.12
2 (InChI) 28.77 20.35 32.59
No errors 59.95 75.60 59.70
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S2, S3. The results from these three sets are shown in 
Table 2.
As expected, the ChEMBL literature set, being derived 
via manual extraction and curation, generates the fewest 
serious penalty scores, although it is clear there are still 
thousands of molecules with an undesirable represen-
tation (e.g. stereo bonds in rings, atoms with multiple 
stereo bonds and molecules with stereo bonds to stere-
ocentres). The PubChem deposited set includes a large 
number of empty molfiles and unknown elements (often 
represented as an asterix, “*”) in addition to molecules 
containing overlapping atoms. The SureChEMBL set 
has a large number of compounds with V3000 formatted 
molfiles, radical entities as well as bonds with illegal ste-
reo flags (usually molfiles with a 4 in the bond stereo field 
of the bond block). The difference between these sets is 
not surprising given the differences in the data sources, 
confirming that the Checker is suitable for identifying a 
range of different issues of differing severity for datasets 
of diverse origin.
A breakdown of the number of compounds from each 
set which returned penalty scores is shown in Table 3. 
When more than one score is returned for a compound 
the highest score is reported. It is worth noting that 
75% of the ChEMBL literature set compounds and 60% 
of both the SureChEMBL and PubChem compound sets 
showed no issues in the Checker tests. When structures 
with a penalty score of 2 associated with InChI Warn-
ings such as “omitted undefined stereo” and “InChI: 
Charges were rearranged” are excluded (as described 
above) then the proportion of compounds with unde-
sirable features that would benefit from correction falls 
to between 4 and 11%.
From a ChEMBL perspective the compounds in 
the latest released version of the database (ChEMBL 
26) have also been subjected to the Checker analysis 
and this has enabled the identification of small sets of 
compounds with particular problems that were not 
previously identified. This dataset is available as an sd 
file on the ChEMBL FTP site [38]. These have been pri-
oritised for curation for a subsequent ChEMBL release. 
The numbers of compounds with penalty scores 5 and 
6 are summarised in Table  4. Those considered to be 
the highest priority for curation are compounds with a 
penalty score of 6 (69 compounds). In future the struc-
tures of molecules with penalty scores of 6 will not be 
added to the database until they have been manually 
checked and corrected.
The ~ 2500 compounds with penalty scores of 5 are 
placed in a group for second-tier curation with the fol-
lowing penalty annotations being prioritised:
• molecule has a crossed bond in a ring (632 com-
pounds). This set does however need to be further 
divided depending on the ring size. It is considered 
a more serious issue for small rings than large rings 
where it is not always clear whether cis, trans or 
either orientation is correct.
• molecule has two (or more) atoms with exactly the 
same coordinates (273 compounds)
Those compounds with mismatches in the number of 
stereocentres will then be addressed.
Standardizer component
Examples of applying the Standardizer to some 
“ChEMBL-like” molecules are shown in Fig.  2. These 
examples show some of the specific standardisations 
described in the methods section for which the Stand-
ardizer component was designed to correct. Also, as 
described above, there will be differences between the 
last two versions of ChEMBL (versions 25 and 26) due 
to the re-standardisation as well as the manual curation 
that took place between the two releases. Comparing the 
structures in these two releases does not give any useful 
statistics on the effectiveness of the new Standardizer. 
Table 4 Checker penalty scores on the current version of ChEMBL (ChEMBL 26)
Compounds where the exclude flag is set are excluded from this analysis
Penalty score Penalty explanation No 
of compounds
6 InChI: Accepted unusual valence(s) 10
Molecule has a radical that is not found in the known list 9
Molecule has six (or more) atoms with exactly the same coordinates 50
5 InChI_RDKit/Mol stereo mismatch 810
Mol/Inchi/RDKit stereo mismatch 6
RDKit_Mol/InChI stereo mismatch 771
Molecule has a crossed bond in a ring 632
Molecule has two (or more) atoms with exactly the same coordinates 259
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Instead, to investigate this, the three sets of molecules 
previously described have been standardised by the new 
Standardizer module. The critical differences are where 
the new standardisation results in a different InChI from 
the one obtained prior to standardisation.
The percentage of molecules with changed InChIs 
are low for all datasets and always < 2% in each case. 
The majority of the changes occur where the Standard-
izer has neutralised a previously charged molecule, for 
example by removing a proton from a positively charged 
nitrogen or protonating a carboxyl group. A summary 
Before Standardisation After Standardisation
a.
b.
c.
d.
e.
Fig. 2 Examples of standardisations that have been applied to a set of compounds. The compound structure before and after standardisation 
is shown. a Fix hypervalent nitro groups, b remove explicit H atoms, c fix covalently drawn alkaline metals connected to O or N to ionic forms, d 
Standardise sulphoxides to charge separated form, e normalise (straighten) allene bonds
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of these changes is shown in Table 5. This also indicates 
which layer of the InChI has changed. Whilst initially 
it may appear that changes to the connectivity layer are 
unexpected for a standardisation process these examples 
are due to salts where the overall molfile is not neutral 
and where a proton has been removed to confer neutral-
ity. To further exemplify this, some examples from the 
Table 5 Summary of  the  number of  compounds that  have changed InChIKeys following  standardisation 
for the SureChEMBL, ChEMBL literature and PubChem deposited set
This also includes the number of compounds in the dataset and the percentage of the total sets with changed InChIKeys
InChIKey layer change SureChEMBL ChEMBL Literature PubChem
Connectivity 15 13 67
Connectivity and Protonation 5 1 33
Protonation 67 297 4358
Stereochemistry 11 0 16
Stereochemistry and Protonation 0 0 4
Total no of changed InChIKeys after standardisation 98 311 4478
Total no of compounds 520174 147008 297864
% changes InChIKeys 0.19 0.21 1.50
Before Standardisation After Standardisation
Fig. 3 Examples of compounds from the ChEMBL literature set where the InChIKey changed on standardisation due to the rebalancing of the 
charge on the compound
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ChEMBL literature set are shown in Fig.  3 where the 
effect of standardisation on neutralising the molecules 
can be observed.
As different databases use different rules to standard-
ise compound structures, it was of interest to compare 
the new ChEMBL Standardizer with the standardiser 
Compound ChEMBL Standardisation PubChem Standardisation
Tipiracil 
Hydrochloride
Doxycycline
Eltrombopag
Minoxidil
Methazolamide
Fig. 4 Examples of approved drugs standardised by the ChEMBL RDKit Standardizer and the PubChem standardiser
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used by the PubChem database [39]. However, as the 
PubChem PUG service was slow to run via their API, 
only a small set of compounds were used for this com-
parison and comprised approved small molecule drugs 
as annotated in ChEMBL 25 (3071 compounds). This 
dataset is provided as an sd file in Supplementary Infor-
mation S4. The ChEMBL 25 structures for these were 
taken and standardised using the new ChEMBL RDKit 
Standardizer and also the PubChem standardiser. In total 
there were 97 compounds that gave different Standard 
InChIKeys after the respective standardisations. The key 
difference is that the PubChem standardiser generates a 
canonical tautomer as part of the process but ChEMBL 
does not. In many instances this is not reflected by a 
change to the Standard InChI but for some molecules the 
InChI does change. There are also some differences in the 
double bond representation (cis or trans (either)). Fur-
thermore, PubChem generates all structures with explicit 
hydrogens which are not present in the ChEMBL struc-
tures. Some of these examples are shown in Fig. 4.
GetParent component
The GetParent module was used to obtain the parent 
structures for the standardised structures from ChEMBL 
where these contained more than one component or an 
isotope. This resulted in over 100,000 compounds where 
a salt, solvent, isotope or combination thereof could be 
removed to create a parent structure. Molfiles that are a 
mixture of components can contain a number of differ-
ent combinations such as: a parent and its salts; a par-
ent, its salts and solvent; a combination of only salts; or a 
true mixture. A true mixture, for example, would include 
compounds such as Co-trimoxazole (CHEMBL58061) 
which is a marketed product comprising trimethoprim 
and sulfamethoxazole and which has been tested as a 
combination in a number of bioactivity assays. Addition-
ally, any of these multicomponent compounds may have 
been tested for bioactivity or used in a clinical setting 
as a specific isotopic form. A summary of the composi-
tion of the multicomponent compounds in ChEMBL 26 
are shown in Fig. 5. Whilst only ~ 6% of the compounds 
in ChEMBL are multicomponent (mostly salts), these 
compounds have over a million activity values recorded 
against them.
Some examples of the output from the GetParent 
process are shown in Fig.  6. This illustrates a number 
of features of the GetParent module including the need 
to re-standardise a parent to some extent once a salt is 
removed, and in particular to re-neutralise the charges 
on the parent molecule. The sodium salt of a carboxyl-
containing compound is an obvious example of this. 
Once the Na+ cation is removed this leaves a net nega-
tive change on the parent so the GetParent module will 
add a proton to neutralise it. Quaternary nitrogen com-
pounds are the exception, where the counterion (for 
example a chloride) is removed but, due to the quater-
nary nature of the nitrogen, it is not possible to neutral-
ise the parent which therefore remains as the positively 
charged cation. Another important function of the Get-
Parent module is that if a compound is a 2:1 complex 
with two parent molecules and one salt molecule, when 
the GetParent module is applied it can recognise that 
the two components remaining after salt removal are 
identical and so only one molecule is returned as the 
Single 
Component 
1,754,196 (1872)
Multiple 
Components 
101,428 (146)
Parent & Salt 
98,126 (127)
Parent & 
Solvent 557
Parent, Salt & 
Solvent 
1031 (2)
Only Solvents 
1
Only Salts 
243 (17)
True Mixture 
1470
Fig. 5 The composition and number of the compounds containing more than one component in ChEMBL 26 as identified by the GetParent 
module. The numbers in brackets refer to the number of compounds in each grouping that contain isotopes
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Example Child Parent 
Parent & Salt 
  
Parent & Salt 
  
Isotope 
  
2:1 Salt 
 
 
Salt of 
quaternary 
nitrogen 
compound 
  
Only Salt 
components with 
isotope   
Parent & Solvent
True Mixture
Parent, Salt & 
Solvent
Fig. 6 Examples of applying the GetParent module to some representative ChEMBL compounds containing varying combinations of salts, isotopes 
and solvents. The “Child” is the compound before and “Parent” the compound after the process has been applied
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parent. Atorvastatin calcium is an example of this as 
can be seen in Fig. 6.
Future work
Now that the components of the curation pipeline are 
being used in a production context for curation of com-
pounds being added to the ChEMBL database, it will pro-
vide opportunities to review and refine any of the rules 
on the basis of a large consistently standardised dataset. 
The ChEMBL group will continue to evolve the cura-
tion pipeline as further needs are identified. The code 
is also now freely available to the community and other 
researchers are encouraged to suggest modifications so 
that the curation pipeline can improve further over time. 
Comments and issues can be added to the issues section 
of the ChEMBL Structure Pipeline GitHub repository 
[28].
Conclusion
The three components of the structure curation pipeline 
described here have been developed as an open source 
project and are now available for researchers to use and 
adapt for their own applications. These components have 
been used by the ChEMBL group to produce the chemi-
cal structures in the latest release of the ChEMBL database 
(ChEMBL26). This has resulted in the correction of cer-
tain errors in standardisation that were present in previous 
ChEMBL releases and the identification of other issues that 
can now be prioritised for future manual curation. Addi-
tionally, the pipeline has been tested on less well curated 
datasets and demonstrated to be sufficiently robust to be 
used in the automatic structure checking and standardi-
sation of such datasets. A comparison between the stand-
ardiser used by PubChem (another large publicly available 
database) and the one developed here gave only a small 
percentage of compounds with non-identical structures 
(defined as having different Standard InChIs). Where such 
differences were present this was largely due to variations 
in the business rules of the two database providers.
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